Disulfiram-Cu decreases the expression of PTEN and the activation of AKT in breast cancer cells. When paired with the PI3K inhibitor LY294002, it significantly suppresses tumor xenograft growth in MDA-MB-231 cells harboring PIK3CA mutations (H1047R and E545K). Here, PIK3CA is linked to breast carcinoma.